Filing Signals

Source: SEC EDGAR Compiled 2026-08-23 04:41 UTC Unattended

← All events

Bespoke Extracts, Inc.

CIK 1409197 BSPK·Pharmaceutical Preparations · All EDGAR filings ↗

Late filing elevated Filing comparison

Bespoke Extracts, Inc. filed its quarterly report late and said it expects a significant change in results

expects significant change in results other reports also outstanding

The Company requires additional time to complete the preparation of the financial statements and related disclosures required to be included in those reports. The interim financial statements to be included in the Form 10-Q for the quarter ended June 30, 2026 include a balance sheet as of December 31, 2025 derived from the Company's audited financial statements for that year, and the Form 10-Q for the quarter ended March 31, 2026 is required to be filed first. Accordingly, the Company is unable to complete and file the Form 10-Q for the quarter ended June 30, 2026 until those reports have been completed.
Evidence
Anticipates significant change
True
Other periodic reports filed
False
Severity
high
Source
Form 12b-25 (notification of late filing)
Stated reason
The Company requires additional time to complete the preparation of the financial statements and related disclosures required to be included in those reports. The interim financial statements to be included in the Form 10-Q for the quarter ended June 30, 2026 include a balance sheet as of December 31, 2025 derived from the Company's audited financial statements for that year, and the Form 10-Q for the quarter ended March 31, 2026 is required to be filed first. Accordingly, the Company is unable to complete and file the Form 10-Q for the quarter ended June 30, 2026 until those reports have been completed.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.